Lv1
80 积分 2021-05-23 加入
Stereotactic Body Radiotherapy Combined With Lenvatinib With or Without PD-1 Inhibitors as Initial Treatment for Unresectable Hepatocellular Carcinoma
1天前
已完结
Long term update of a phase 3 randomized study comparing once-a-week versus once-every-3-weeks cisplatin along with radiation in head and neck cancer
1天前
已完结
Efficacy and safety of the “watch-and-wait” approach for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy: a meta-analysis
1个月前
已完结
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study
1个月前
已完结
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial
7个月前
已完结
Upfront Treatment With Osimertinib vs. Osimertinib and Radiotherapy for Patients With EGFR-Positive Non-Small Cell Lung Cancer Brain Metastases
11个月前
已完结
A simple dose gradient measurement tool to complement the conformity index
11个月前
已完结
Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curves
11个月前
已完结
皖公网安备34019202002308
